510(k) Report

510(k) · Cleared

Cleared

TRV

K192652510(k) TraditionalCleared May 27, 2020246-day reviewClass U

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Interacoustics A/S · LXV Apparatus, Vestibular Analysis

Cleared on May 27, 2020 as substantially equivalent to K071973 (Vesticon, 2008) after a 246-day review. Its family tree reaches back 3 generations to 1995.

Decided
May 27, 2020
Review
246 days
Class
Class U
Product code
LXV
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K946229 (1995). 6 ancestors in all, the oldest K863424 (1987). No later device cites it as a predicate yet.

Other ancestors, by year cleared 1997: 1 other ancestor1992: 1 other ancestor1987: 1 other ancestorK946229 · Balance Manager · Neurocom International, Inc. · 1995K070085 · Balance Rehabilitation Unit (Bru) · Medicaa (Uruguay) S.A. · 2007K071973 · Epley Omniax · Vesticon · 20081990200020102020
  1. Root · 3 generations backK946229 Balance ManagerNeurocom International, Inc. · 1995
  2. 2 generations backK070085 Balance Rehabilitation Unit (Bru)Medicaa (Uruguay) S.A. · 2007
  3. 1 generation backK071973 Epley OmniaxVesticon · 2008
  4. This deviceK192652 TRVInteracoustics A/S · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K946229Balance ManagerNeurocom International, Inc.1995—
−2K070085Balance Rehabilitation Unit (Bru)Medicaa (Uruguay) S.A.2007—
−1K071973Epley OmniaxVesticon2008—
0 (this device)K192652TRVInteracoustics A/S2020—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198710
199210
199710
FIG. 1 — Lineage of K192652, 1995–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LXV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LXV device

  1. #1 K220231 GyroStimscore 3.8 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K071973Epley Omniax
Summary page 4
…Unclassified Predicate Device: Predicate Device Epley OmniaxTM Manufacturer Vesticon inc 510(k) No. K071973 Date Cleared 06/20/2008 Device description The TRV is a multi-axial chair that can rotate 360° around both…
Vesticon2008—

Also cleared against K071973: 2 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 4 companies; a new generation was cleared every 11.6 years on median.
  • None of the 6 ancestors has a recall.
  • 2 other devices also cite its predicate K071973.

How does its category compare?

All LXV devices

LXV Apparatus, Vestibular Analysis: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · LXV

1in 2022

2007: 22008: 22009: 12010: 12012: 12018: 12019: 22020: 22022: 1
2007high 2 (2007) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LXV

Too few LXV 510(k)s in any year since 2007 to give a median.

Recalls per year · LXV

1in 2009

2008: 12009: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LXV

1in 2010

2007: 12010: 1
2007high 1 (2007) · low 0 (2008)2025

MAUDE reports naming product code LXV, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—01
20082—10
20091—10
20101—01
20110—00
20121—00
20130—00
20140—00
20150—00
20160—00
20170—00
20181—00
20192—00
20202—00
20210—00
20221—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The TRV is intended to assist in the diagnosis and treatment of balance disorders and vertigo, including benign paroxysmal positional vertigo.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K192652: TRV.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K192652

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026